Mögliche Grenzwert-überschreitende DNA-Menge in mRNA-Impfstoffen

This is a written parliamentary inquiry concerning the presence of residual DNA fragments in mRNA vaccines. The procedure seeks to clarify whether these levels exceed established safety limits and what the potential implications are for public health. The inquiry primarily affects health regulators and vaccine manufacturers, focusing on quality control standards and the transparency of safety data for citizens.